The (new) top 10 phar­ma com­pa­nies by 2017 rev­enue

Take­da CEO Christophe We­ber will now be able to boast about his el­e­va­tion in­to the top 10 glob­al phar­ma com­pa­nies, if you base the count on rev­enue. 

I cob­bled to­geth­er the lat­est set of fig­ures for fis­cal 2017 to show you where the Take­da/Shire op­er­a­tion fits in to the big pic­ture. I’ll note that while J&J is way out front, it’s a health­care/phar­ma con­glom­er­ate with a wide range of prod­ucts in its port­fo­lio. And I backed out crop sci­ences rev­enue from Bay­er to make this more about bio­phar­ma.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.